Drug resistance outcomes of long-term ART with tenofovir disoproxil fumarate in the absence of virological monitoring-Reference-Cited by-同舟云学术

Drug resistance outcomes of long-term ART with tenofovir disoproxil fumarate in the absence of virological monitoring

Published:2018-07-18 Issue:11 Volume:73 Page:3148-3157
ISSN:0305-7453
Container-title:Journal of Antimicrobial Chemotherapy
language:en
Short-container-title:

Author:

Villa Giovanni¹^ORCID,Phillips Richard O²³,Smith Colette⁴,Stockdale Alexander J¹⁵,Ruggiero Alessandra¹,Beloukas Apostolos¹^ORCID,Appiah Lambert T³,Chadwick David⁶,Sarfo Fred S³,Geretti Anna Maria¹

Affiliation:

1. Institute of Infection & Global Health, University of Liverpool, Liverpool, UK

2. Department of Medicine, Kwame Nkrumah University of Science & Technology, Kumasi, Ghana

3. Komfo Anokye Teaching Hospital, Kumasi, Ghana

4. Department of Infection & Population Health, University College London, London, UK

5. Malawi-Liverpool-Wellcome Trust Clinical Research Programme, Blantyre, Malawi

6. Centre for Clinical Infection, James Cook University Hospital, Middlesbrough, UK

Funder

Gilead Sciences, Inc.

European AIDS Clinical Society, Leverhulme-Royal Society Africa

MAC AIDS Foundation

Royal College of Physicians of Edinburgh

Wellcome Trust

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology,Microbiology (medical)

Link

http://academic.oup.com/jac/article-pdf/73/11/3148/26144601/dky281.pdf

Reference47 articles.

1. Epidemiology and impact of HIV coinfection with hepatitis B and hepatitis C viruses in sub-Saharan Africa;Matthews;J Clin Virol,2014

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A detailed characterization of drug resistance during darunavir/ritonavir monotherapy highlights a high barrier to the emergence of resistance mutations in protease but identifies alternative pathways of resistance;Journal of Antimicrobial Chemotherapy;2023-12-28

2. A detailed characterisation of drug resistance during darunavir/ritonavir (DRV/r) monotherapy highlights a high barrier to the emergence of resistance mutations in protease but identifies alternative pathways of resistance;2023-10-15

3. High-level resistance to non-nucleos(t)ide reverse transcriptase inhibitor based first-line antiretroviral therapy in Ghana; A 2017 study;Frontiers in Microbiology;2022-08-25

4. Advancements in the prevention of hepatitis B recurrence by nucleos(t)ide analogue monotherapies after liver transplantation;European Journal of Inflammation;2022-01

5. Application of next generation sequencing in HIV drug resistance studies in Africa, 2005–2019: A systematic review;Scientific African;2021-07